The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Objective response by mRECIST to predict survival in hepatocellular carcinoma: A multivariate, time-dependent analysis from the phase III BRISK-PS study.
 
Josep M. Llovet
Honoraria - Bayer Schering Pharma; Blueprint Medicines; Bristol-Myers Squibb; Celsion
Consulting or Advisory Role - Bayer Schering Pharma; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Celsion; Lilly/ImClone
Research Funding - Bayer Schering Pharma; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bayer Schering Pharma
 
Joong-Won Park
No Relationships to Disclose
 
Ferran Torres
No Relationships to Disclose
 
Thomas Decaens
No Relationships to Disclose
 
Eveline Boucher
No Relationships to Disclose
 
Jean-Luc Raoul
No Relationships to Disclose
 
Masatoshi Kudo
No Relationships to Disclose
 
Charissa Chang
No Relationships to Disclose
 
Valerie Boige
No Relationships to Disclose
 
Eric Assenat
No Relationships to Disclose
 
Yoon-Koo Kang
Consulting or Advisory Role - Lilly/ImClone; Novartis; Ono Pharmaceutical; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Bayer; Novartis; Roche/Genentech
 
Ho-Yeong Lim
No Relationships to Disclose
 
Ian Walters
No Relationships to Disclose
 
Riccardo Lencioni
Consulting or Advisory Role - Bristol-Myers Squibb